Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Vera Therapeutics Inc (NASDAQ: VERA) was $48.41 for the day, down -1.41% from the previous closing price of $49.1. In other words, the price has decreased by -$1.41 from its previous closing price. On the day, 1.27 million shares were traded. VERA stock price reached its highest trading level at $49.7527 during the session, while it also had its lowest trading level at $47.15.
Ratios:
Our analysis of VERA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.09 and its Current Ratio is at 12.09. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In the most recent recommendation for this company, BofA Securities on October 16, 2025, initiated with a Buy rating and assigned the stock a target price of $48.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 15 ’25 when Turner William D. sold 10,000 shares for $50.08 per share. The transaction valued at 500,767 led to the insider holds 22,500 shares of the business.
ENRIGHT PATRICK G bought 5,882 shares of VERA for $249,985 on Dec 11 ’25. The Director now owns 5,882 shares after completing the transaction at $42.50 per share. On Dec 15 ’25, another insider, WILLIAM TURNER, who serves as the Officer of the company, bought 10,000 shares for $49.80 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 3436475136 and an Enterprise Value of 2674584576.
Stock Price History:
The Beta on a monthly basis for VERA is 1.15, which has changed by 0.4978646 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, VERA has reached a high of $56.05, while it has fallen to a 52-week low of $18.53. The 50-Day Moving Average of the stock is 20.18%, while the 200-Day Moving Average is calculated to be 72.81%.
Shares Statistics:
VERA traded an average of 1.54M shares per day over the past three months and 1176020 shares per day over the past ten days. A total of 63.89M shares are outstanding, with a floating share count of 54.80M. Insiders hold about 23.88% of the company’s shares, while institutions hold 83.81% stake in the company. Shares short for VERA as of 1767139200 were 8459021 with a Short Ratio of 5.49, compared to 1764288000 on 10818660. Therefore, it implies a Short% of Shares Outstanding of 8459021 and a Short% of Float of 13.520001.
Earnings Estimates
The performance of Vera Therapeutics Inc (VERA) in the stock market is under the watchful eye of 8.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$1.23, with high estimates of -$0.98 and low estimates of -$1.67.
Analysts are recommending an EPS of between -$3.86 and -$4.96 for the fiscal current year, implying an average EPS of -$4.44. EPS for the following year is -$4.52, with 8.0 analysts recommending between -$3.18 and -$6.05.
